Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis

Samuel Antwi, Todd M. Everson

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Background: This study investigated whether definitive local therapy [radical prostatectomy (RP) or brachytherapy (BT)] of the primary tumor improves survival in men with metastatic prostate cancer (PrCA) at diagnosis. Methods: Data on newly diagnosed metastatic PrCA cases (stage IV, N= 7858) were obtained from the Surveillance Epidemiology and End Results (SEER) program. Conventional multivariable survival analysis and propensity score analysis were used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (95% CI) comparing men who underwent definitive local therapy of the primary tumor to those who did not. Results: After adjusting for sociodemographic and tumor attributes, having RP after diagnosis with metastatic PrCA was associated with 73% (HR. = 0.27, 95% CI: 0.20-0.38) lower risk of all-cause mortality and 72% (HR. = 0.28, 95% CI: 0.20-0.39) reduced risk of death from PrCA. Having BT also was associated with 57% (HR. = 0.43, 95% CI: 0.31-0.59) and 54% (HR. = 0.46, 95% CI: 0.33-0.64) lower risk of all-cause and PrCA-specific mortality. Similar results were observed in propensity score-adjusted analysis as well as when stratified by age and extent of tumor metastasis. Conclusions: These findings suggest that definitive local therapy improves survival in men with metastatic PrCA at diagnosis. Future work should consider comorbidities, diet, physical activity and smoking status.

Original languageEnglish (US)
Pages (from-to)435-441
Number of pages7
JournalCancer Epidemiology
Volume38
Issue number4
DOIs
StatePublished - Aug 2014

Keywords

  • Definitive therapy
  • Metastasis
  • Prostate cancer
  • SEER data
  • Stage IV prostate cancer
  • Survival

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis'. Together they form a unique fingerprint.

  • Cite this